knowledge -WSS

knowledge

author：comprehensive 2025-09-28 00:47:38 - browse：231

From left: Daphne Koller, CEO of Insitro, Vijay Pande of Andreessen Horowitz and scientist Derek Lowe speaking at STAT's Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

Artificial intelligence is a rapidly improving technology. But its progress in drug development faces an increasingly urgent threat: An unending stream of overheated marketing.

To read of AI’s feats in press releases is to learn of a miracle product on the verge of unraveling biology’s most enduring secrets. It can map molecules and accurately predict how they fit together on computer screens. All you need to get to a cure — as they say in infomercials — is act now!

“I am very worried about the hype,” said Daphne Koller, chief executive of the machine learning drug discovery company Insitro, said during STAT’s Breakthrough West Summit in San Francisco last week. “People think (the breakthrough) is going to happen tomorrow.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： NIH documents show early flaws of $1.6 billion long Covid program

WSS

Ionis drug prevents swelling attacks due to hereditary angioedema

NIH documents show early flaws of $1.6 billion long Covid program

Allen Institute goes after foundational questions, CEO Costa says

Male doctors called my cancer incurable. A female doctor showed it wasn't

Fauci's latest grilling in Congress: 9 hours, behind closed doors

At JPM 2024, hospital systems pitch financial strength to investors

entertainment

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

entertainment

What does generative AI mean for health care? We asked experts

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Wildfire smoke exposes gaps in outdoor worker protections

ASCO: Palliative care found as helpful given virtually as in person

Supreme Court strikes down use of affirmative action

Medicare Advantage overpayments discussion gets experts fired up

Medicare details structure of new drug price negotiation program

The Pandemic Treaty must support building strong health systems

Duchenne breakthrough therapy leaves behind pioneering families

At JPM 2024, hospital systems pitch financial strength to investors

hotspot

HIV drugs protect against transmission, even in unprotected sex

Ascension's ugly legal battle over care for poor patients in Texas

Ionis drug prevents swelling attacks due to hereditary angioedema

ASCO: AstraZeneca says CAR

JPM pitch from hospitals? Revenue streams outside of patient care

NIH documents show early flaws of $1.6 billion long Covid program

entertainment

Wikipedia

leisure time

leisure time